Mozenavir mesilate

N/A

Report date: 2022/05/18 16:21:34
NME

Base Information

Drug NameMozenavir mesilate
Drug Alias Name莫扎那韦XM-412DPC-450DMP-450
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV protease inhibitors
TargetsHIV protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksKEGG